The findings of this study revealed potential biomarkers and therapeutic targets in the ferroptosis signaling pathway, and four differential expression of ferroptosis-related lncRNAs (AC099850.3, LUCAT1, AC016405.3, and MKLN1-A) were independent prognostic factors for HCC. This evidence concerns the gene LUCAT1 and hepatocellular carcinoma.